Primary interstitial lung disease specific to childhood

disease
On this page

Also known as cHILDchildren's interstitial lung diseaseprimary ILD specific to childhood

Summary

Primary interstitial lung disease specific to childhood (MONDO:0017015) is a disease (an umbrella term covering 5 Mondo subtypes) and 228 clinical trials. Top therapeutic interventions include clemastine, thiamine ion, and brentuximab vedotin. A subtype of interstitial lung disease specific to childhood — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 5 Mondo subtypes
  • Clinical trials: 228

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameprimary interstitial lung disease specific to childhood
Mondo IDMONDO:0017015
Orphanet264665
ICD-111408868257
UMLSC3161253
MedGen853969
GARD0010559
Is cancer (heuristic)no

Also known as: cHILD · children’s interstitial lung disease · primary ILD specific to childhood · primary interstitial lung disease specific to childhood

Disease family

This is a subtype of interstitial lung disease specific to childhood. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorderlower respiratory tract disorderlung disorderinterstitial lung diseaseinterstitial lung disease specific to childhoodprimary interstitial lung disease specific to childhood

Related subtypes (4): Niemann-Pick disease type B, Hermansky-Pudlak syndrome with pulmonary fibrosis, familial hypocalciuric hypercalcemia, congenital emphysematous lung disease due to Filamin A loss-of-function variant

Subtypes (5): alveolar capillary dysplasia with misalignment of pulmonary veins, congenital chylothorax, lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome, interstitial lung disease specific to infancy, newborn respiratory distress syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 228.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified202
PHASE413
PHASE36
PHASE25
PHASE2/PHASE32

Top trials by phase / activity

NCTPhaseStatusTitle
NCT04577690PHASE4RECRUITINGPECS Study for CIED Implantation Surgery
NCT06320626PHASE4RECRUITINGPharmacokinetic-guided Dosing of Emicizumab
NCT00462371PHASE4COMPLETEDComparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 Children
NCT01154595PHASE4COMPLETEDEffectiveness of a Ready-to-Use-Food (RUF) Supplement to Prevent Acute Child Malnutrition
NCT01204411PHASE4WITHDRAWNEfficacy of Artesunate-amodiaquine (AS-AQ) in Children With Malaria and Severe Acute Malnutrition, Madaoua, Niger 2010
NCT02248493PHASE4COMPLETEDIntravenous Paracetamol for Postoperative Pain
NCT02300701PHASE4COMPLETEDRole of Anti-IgE in Severe Childhood Eczema
NCT02464865PHASE4COMPLETEDThiamin Deficiency in Obese Thai Children
NCT02738814PHASE4UNKNOWNPropofol for Treatment on Emergence Agitation
NCT02985177PHASE4WITHDRAWNA RCT of a Combination of Analgesics for Pain Management in Children With a Suspected Fracture
NCT03426462PHASE4COMPLETEDTime to Peak Effect of Propofol in Children
NCT05515887PHASE4COMPLETEDInfluence of Shenqu Xiaoshi Oral Liquid on Intestinal Microbiome of Children With Functional Dyspepsia
NCT06037915PHASE4COMPLETEDAirway Interventions During Intravenous Anesthesia in Children Undergoing Direct Laryngoscopy for Surgical Procedures Using High Flow Nasal Versus Low Flow Oxygen. A Pilot Study.(Flowkid)
NCT06563245PHASE2/PHASE3RECRUITINGBrentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
NCT07336095PHASE3NOT_YET_RECRUITINGMelatonin vs Midazolam in Children Undergoing Tonsillectomy
NCT00408135PHASE3COMPLETEDJapanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections
NCT01122927PHASE3TERMINATEDSafety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
NCT01552642PHASE3COMPLETEDAn Interactive Web-based Intervention to Achieve Healthy Weight in Young Children
NCT02338440PHASE2/PHASE3UNKNOWNPharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT
NCT02348073PHASE3COMPLETEDEfficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
NCT05799053PHASE3COMPLETEDPeppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study
NCT05999994PHASE2RECRUITINGA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
NCT02339350PHASE2UNKNOWNTreatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children
NCT03741101PHASE2UNKNOWNTreatment of NF1-related Plexiform Neurofibroma With Trametinib
NCT06164600PHASE2COMPLETEDBovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
NCT06315699PHASE2COMPLETEDClemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome
NCT02852928Not specifiedRECRUITINGEuropean Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank
NCT03426579Not specifiedRECRUITINGCorrelation Between Sedation Depth Monitoring and Reflexes During Intravenous Anesthesia With Dexmedetomidine and Remifentanil in Children Undergoing Direct Laryngoscopy for Surgical Procedures
NCT04022460Not specifiedACTIVE_NOT_RECRUITINGUsing Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
NCT04528810Not specifiedNOT_YET_RECRUITINGA Study of Child Injury Based on Data Mining
NCT04989790Not specifiedRECRUITINGClinical Effectiveness of the PICU Up! Multifaceted Early Mobility Intervention for Critically Ill Children
NCT05016271Not specifiedACTIVE_NOT_RECRUITINGHealth Benefits of Air Purifiers in Primary School Students
NCT05615324Not specifiedACTIVE_NOT_RECRUITINGSAFIR Family Talk - Investigating the Effect of The Family Talk Intervention
NCT05790785Not specifiedRECRUITINGVascular Complications in Children From T1D Diagnosis
NCT05849753Not specifiedRECRUITINGBreaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
NCT05914324Not specifiedACTIVE_NOT_RECRUITINGOutpatient Pediatric Pulse Oximeters in Africa
NCT06047821Not specifiedACTIVE_NOT_RECRUITINGEnterics for Global Health (EFGH)
NCT06092671Not specifiedRECRUITINGEffect of FPCA on Incidence of Emergency Delirium in Children After Surgery
NCT06312410Not specifiedRECRUITINGThe VIA Family 2.0 - a Family Based Intervention for Families with Parental Mental Illness
NCT06400667Not specifiedACTIVE_NOT_RECRUITINGFunctional Assessment Protocol for the Upper Limb for Pediatric Age

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
CLEMASTINE43
THIAMINE ION42
BRENTUXIMAB VEDOTIN41
DACARBAZINE41
HYDROCODONE41
IBUPROFEN41
KETOPROFEN41
MORPHINE41
OMALIZUMAB41
TELITHROMYCIN41
TISLELIZUMAB41
TRAMADOL41
TRAMETINIB41
WATER41
PEPPERMINT31
STARCH, CORN31
CHEMBL405972201
CHEMBL458922601
CHEMBL559209001
CHEMBL121584801
CHEMBL157417901
CHEMBL543395001
(R,R)-TRAMADOL01